Related Experiment Video
Updated: Jul 16, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Meta-analysis: Helicobacter pylori eradication treatment efficacy in children
R Khurana1, L Fischbach, N Chiba
1Community Oriented Primary Care, Parkland Health & Hospital Systems, Dallas, TX 75224, USA. renu.khurana@sbcglobal.net
This meta-analysis found that while some Helicobacter pylori (H. pylori) treatment regimens show promise in children, more high-quality trials are needed. Efficacious therapies varied by region, highlighting the need for further research, especially in developing nations.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Evidence-Based Medicine
Background:
- Limited meta-analyses exist for pediatric Helicobacter pylori (H. pylori) treatment efficacy.
- Existing studies on H. pylori eradication in children lack comprehensive analysis.
Purpose of the Study:
- To synthesize the effectiveness of H. pylori eradication treatments in pediatric populations.
- To identify factors influencing treatment success rates across different studies.
Main Methods:
- Systematic literature search of Medline, reference lists, and conference proceedings.
- Inclusion of 80 studies involving 4436 children with H. pylori infections.
- Application of weighted meta-regression models to analyze efficacy variations.
Main Results:
- Methodological quality of included studies was generally poor, with small sample sizes and few RCTs.
- Treatment efficacy for H. pylori varied significantly based on regimen, duration, assessment method, and geographic location.
- Specific regimens, including those with nitroimidazoles, amoxicillin, clarithromycin, proton pump inhibitors, macrolides, or bismuth, demonstrated higher efficacy in developed countries.
Conclusions:
- Further well-designed, randomized, placebo-controlled pediatric trials are essential for establishing global H. pylori treatment guidelines.
- There is a critical need for more research in developing countries due to high H. pylori drug resistance and disease burden.
More Related Videos
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology
Gastritis II: Pathophysiology